Alexander disease

Jump to navigation Jump to search

Template:DiseaseDisorder infobox

WikiDoc Resources for Alexander disease

Articles

Most recent articles on Alexander disease

Most cited articles on Alexander disease

Review articles on Alexander disease

Articles on Alexander disease in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Alexander disease

Images of Alexander disease

Photos of Alexander disease

Podcasts & MP3s on Alexander disease

Videos on Alexander disease

Evidence Based Medicine

Cochrane Collaboration on Alexander disease

Bandolier on Alexander disease

TRIP on Alexander disease

Clinical Trials

Ongoing Trials on Alexander disease at Clinical Trials.gov

Trial results on Alexander disease

Clinical Trials on Alexander disease at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Alexander disease

NICE Guidance on Alexander disease

NHS PRODIGY Guidance

FDA on Alexander disease

CDC on Alexander disease

Books

Books on Alexander disease

News

Alexander disease in the news

Be alerted to news on Alexander disease

News trends on Alexander disease

Commentary

Blogs on Alexander disease

Definitions

Definitions of Alexander disease

Patient Resources / Community

Patient resources on Alexander disease

Discussion groups on Alexander disease

Patient Handouts on Alexander disease

Directions to Hospitals Treating Alexander disease

Risk calculators and risk factors for Alexander disease

Healthcare Provider Resources

Symptoms of Alexander disease

Causes & Risk Factors for Alexander disease

Diagnostic studies for Alexander disease

Treatment of Alexander disease

Continuing Medical Education (CME)

CME Programs on Alexander disease

International

Alexander disease en Espanol

Alexander disease en Francais

Business

Alexander disease in the Marketplace

Patents on Alexander disease

Experimental / Informatics

List of terms related to Alexander disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Dysmyelogenic leukodystrophy, Dysmyelogenic leukodystrophy-megalobare, Fibrinoid degeneration of astrocytes, Fibrinoid leukodystrophy, Hyaline panneuropathy, Leukodystrophy with Rosenthal fibers, Megalencephaly with hyaline inclusion, Megalencephaly with hyaline panneuropathy

Overview

Alexander disease is a slowly progressing and fatal neurodegenerative disease. It is a very rare disorder which results from a genetic mutation and mostly affects infants and children, causing developmental delay and changes in physical characteristics.

Pathophysiology

Alexander disease is inherited in an autosomal dominant pattern.

The cause of Alexander disease is a mutation in the gene encoding glial fibrillary acidic protein.

Alexander disease is a genetic disorder affecting the central nervous system (midbrain and cerebellum). It is caused by mutations in the gene for glial fibrillary acidic protein (GFAP) that maps to chromosome 17q21. It is inherited in an autosomal dominant manner.

Alexander disease belongs to leukodystrophies, a group of diseases which affect growth or development of the myelin sheath. The destruction of white matter in the brain is accompanied by the formation of fibrous, eosinophilic deposits known as Rosenthal fibers.

Epidemiology and Demographics

This is a very rare with no more than 300 cases reported. The infantile form (80% of all cases) starts usually at the age of six months or within the first two years. The average duration of the infantile form of the illness is usually about 3 years. Onset of the juvenile form (14% of all cases) presents usually between four to ten years of age. Duration of this form is in most cases about 8 years. In younger patients, seizures, megalencephaly, developmental delay, and spasticity are usually present. Neonatal onset is also reported. Onset in adults is least frequent. In older patients, bulbar or pseudobulbar symptoms and spasticity predominate. Symptoms of the adult form may also resemble multiple sclerosis.

Natural History, Complications and Prognosis

The prognosis is generally poor. With early onset, death usually occurs within 10 years after the onset of symptoms. Usually, the later the disease occurs, the slower its course is.

Diagnosis

Symptoms

Delays in development of some physical, psychological and behavioral skills, progressive enlargement of the head (macrocephaly), seizures, spasticity, in some cases also hydrocephalus, dementia, clumsy movements.

CT Findings

  • decreased density of white matter
  • frontal lobe predominance
  • +/- dilated lateral ventricles

Treatment

There is neither cure nor standard treatment for Alexander disease. All treatment is symptomatic and supportive, for example antibiotics for intercurrent infection and anticonvulsants for seizure control are usually used.

See also

External links

de:Alexander-Krankheit fi:Aleksanterin tauti


Template:WS